Browse by Section 100 Item List

HIGHLY SPECIALISED DRUGS PROGRAM (Public Hospital)

For Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule. Highly Specialised Drugs prescribed through public hospitals, except Complex Authority Required Highly Specialised Drugs, are Authority required (STREAMLINED) PBS Prescriptions. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats. Complex Authority Required Highly Specialised Drugs require written authority applications. Approval of authority prescriptions by Services Australia may be obtained either by posting an Authority Prescription Form to Services Australia, or by using the Services Australia Authority free-call service (1800 888 333). Prescribers must quote the provider number of the hospital when applying.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies. A patient will be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the Pharmaceutical Benefits Scheme. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
  • SO
    Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
    Supply Only
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 5776B LANREOTIDElanreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack 2 2 11
MP 11513Y LANREOTIDElanreotide 120 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 5779E LANREOTIDElanreotide 120 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 5777C LANREOTIDElanreotide 60 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 5778D LANREOTIDElanreotide 90 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 5781G LANTHANUMlanthanum 750 mg chewable tablet, 6 x 15 2 180 5
MP 5780F LANTHANUMlanthanum 500 mg chewable tablet, 2 x 45 2 180 5
MP 5782H LANTHANUMlanthanum 1 g chewable tablet, 6 x 15 2 180 5
MPNP 10661D LEDIPASVIR + SOFOSBUVIRledipasvir 90 mg + sofosbuvir 400 mg tablet, 28 1 28 2
MPNP 10667K LEDIPASVIR + SOFOSBUVIRledipasvir 90 mg + sofosbuvir 400 mg tablet, 28 1 28 1
MPNP 10669M LEDIPASVIR + SOFOSBUVIRledipasvir 90 mg + sofosbuvir 400 mg tablet, 28 1 28 5
MP 12019N LENALIDOMIDElenalidomide 25 mg capsule, 14 1 14 3
MP 11062F LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 0
MP 12026Y LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 3
MP 12062W LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 1
MP 5785L LENALIDOMIDElenalidomide 15 mg capsule, 21 1 21 0
MP 11029L LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 0
MP 12034J LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 3
MP 12039P LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 1
MP 2799H LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 3
MP 5783J LENALIDOMIDElenalidomide 5 mg capsule, 21 1 21 0
MP 12012F LENALIDOMIDElenalidomide 15 mg capsule, 14 1 14 3
MP 11968X LENALIDOMIDElenalidomide 10 mg capsule, 28 1 28 2
MP 11964Q LENALIDOMIDElenalidomide 15 mg capsule, 28 1 28 2
MP 12035K LENALIDOMIDElenalidomide 5 mg capsule, 14 1 14 3
MP 11967W LENALIDOMIDElenalidomide 5 mg capsule, 28 1 28 2
MP 12070G LENALIDOMIDElenalidomide 10 mg capsule, 14 1 14 3
MP 11064H LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 0
MP 12057N LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 1
MP 12061T LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 3
MP 2802L LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 3
MP 5784K LENALIDOMIDElenalidomide 10 mg capsule, 21 1 21 0
MP 11041D LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 0
MP 12036L LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 1
MP 12059Q LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 3
MP 5786M LENALIDOMIDElenalidomide 25 mg capsule, 21 1 21 0
MP 11550X LENOGRASTIMlenograstim 13.4 million units (105 microgram) injection, 1 vial 2 20 11
MP 11551Y LENOGRASTIMlenograstim 33.6 million units (263 microgram) injection, 1 vial 2 20 11
MP 11913B LEVODOPA + CARBIDOPAlevodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL 4 28 5
MP 9743T LEVODOPA + CARBIDOPAlevodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL 8 56 5
MP 10936N LIPEGFILGRASTIMlipegfilgrastim 6 mg/0.6 mL injection, 0.6 mL syringe 1 1 11
MP 11866M LUMACAFTOR + IVACAFTORlumacaftor 100 mg + ivacaftor 125 mg granules, 56 sachets 1 56 5
MP 11465K LUMACAFTOR + IVACAFTORlumacaftor 100 mg + ivacaftor 125 mg tablet, 112 1 112 5
MP 11851R LUMACAFTOR + IVACAFTORlumacaftor 150 mg + ivacaftor 188 mg granules, 56 sachets 1 56 5
MP 11466L LUMACAFTOR + IVACAFTORlumacaftor 200 mg + ivacaftor 125 mg tablet, 112 1 112 5